rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Keith R. Harris

Director

Company insider

Files Form 4 as: Director, MeiraGTx Holdings; Director, vTv Therapeutics.

In numbers

Trades disclosed
25
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
2
Companies where not an officer
2
First trade
19 Jun 2019
Last trade
11 Jun 2026
Last filed
15 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
MGTX MeiraGTx HoldingsDirector · Biotechnology · last 11 Jun 20260 buys · 0 sells
VTVT vTv TherapeuticsDirector · Biotechnology · last 19 Jun 20230 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
11 Jun 2026filed 15 Jun 2026MGTX MeiraGTx Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—106,441 at $0.00filing
11 Jun 2026filed 15 Jun 2026MGTX MeiraGTx Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—106,441 at $0.00filing
10 Jun 2026filed 10 Jun 2026MGTX MeiraGTx HoldingsBiotechnologySEC FORM 4 Code M—75,000filing
10 Jun 2026filed 10 Jun 2026MGTX MeiraGTx Holdingsoption or derivative · BiotechnologySEC FORM 4 Code M—75,000 at $0.00filing
10 Jun 2026filed 10 Jun 2026MGTX MeiraGTx Holdingsoption or derivative · BiotechnologySEC FORM 4 Code M—75,000 at $0.00filing
10 Jun 2026filed 10 Jun 2026MGTX MeiraGTx HoldingsBiotechnologySEC FORM 4 Code M—75,000filing
12 Jun 2025filed 16 Jun 2025MGTX MeiraGTx Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—45,000 at $0.00filing
12 Jun 2025filed 16 Jun 2025MGTX MeiraGTx Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—75,000 at $0.00filing
6 Jun 2025filed 9 Jun 2025MGTX MeiraGTx Holdingsoption or derivative · BiotechnologySEC FORM 4 Code M—75,000 at $0.00filing
6 Jun 2025filed 9 Jun 2025MGTX MeiraGTx HoldingsBiotechnologySEC FORM 4 Code M—75,000filing
6 Jun 2024filed 6 Jun 2024MGTX MeiraGTx Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—75,000 at $0.00filing
5 Jun 2024filed 6 Jun 2024MGTX MeiraGTx Holdingsoption or derivative · BiotechnologySEC FORM 4 Code M—30,000 at $0.00filing
5 Jun 2024filed 6 Jun 2024MGTX MeiraGTx HoldingsBiotechnologySEC FORM 4 Code M—30,000filing
19 Jun 2023filed 21 Jun 2023VTVT vTv Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—75,000 at $0.00filing
8 Jun 2023filed 9 Jun 2023MGTX MeiraGTx Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
8 Jun 2023filed 9 Jun 2023MGTX MeiraGTx Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
7 Jun 2023filed 9 Jun 2023MGTX MeiraGTx Holdingsoption or derivative · BiotechnologySEC FORM 4 Code M—20,000 at $0.00filing
7 Jun 2023filed 9 Jun 2023MGTX MeiraGTx HoldingsBiotechnologySEC FORM 4 Code M—20,000filing
13 Jul 2022filed 17 Aug 2022VTVT vTv Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
7 Jun 2022filed 9 Jun 2022MGTX MeiraGTx Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Richard GirouxCFO & COO · CFO & COO at MeiraGTx Holdings, filing Form 4 there in the last year
Stuart NaylorChief Sci Ofcr, Ophthalmology · Chief Sci Ofcr, Ophthalmology at MeiraGTx Holdings, filing Form 4 there in the last year
Alan SebulskyDirector · Director at MeiraGTx Holdings, filing Form 4 there in the last year
Alexandria ForbesPresident & CEO · President & CEO at MeiraGTx Holdings, filing Form 4 there in the last year
Robert K. ZeldinChief Medical Officer · Chief Medical Officer at MeiraGTx Holdings, filing Form 4 there in the last year